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While aging is a critical risk factor for heart failure, it remains uncertain whether the
aging heart responds differentially to a hypertensive stimuli. Here we investigated
phenotypic and transcriptomic differences between the young and aging heart using
a mineralocorticoid-excess model of hypertension. Ten-week (“young”) and 36-week
(“aging”) mice underwent a unilateral uninephrectomy with deoxycorticosterone acetate
(DOCA) pellet implantation (n = 6–8/group) and were followed for 6 weeks. Cardiac
structure and function, blood pressure (BP) and the cardiac transcriptome were
subsequently examined. Young and aging DOCA mice had high BP, increased
cardiac mass, cardiac hypertrophy, and fibrosis. Left ventricular end-diastolic pressure
increased in aging DOCA-treated mice in contrast to young DOCA mice. Interstitial and
perivascular fibrosis occurred in response to DOCA, but perivascular fibrosis was greater
in aging mice. Transcriptomic analysis showed that young mice had features of higher
oxidative stress, likely due to activation of the respiratory electron transport chain. In
contrast, aging mice showed up-regulation of collagen formation in association with
activation of innate immunity together with markers of inflammation including cytokine
and platelet signaling. In comparison to younger mice, aging mice demonstrated
different phenotypic and molecular responses to hypertensive stress. These findings
have potential implications for the pathogenesis of age-related forms of cardiovascular
disease, particularly heart failure.
Keywords: heart failure, aging, fibrosis, microRNAs, miRNAs, miRs, transcriptome, pathways
INTRODUCTION
One of the major and most inevitable risk factor for the development of heart failure is aging,
particularly when combined with hypertension (Owan et al., 2006). With improvements in lifespan,
the prevalence of heart failure has increased in the past decade, and is estimated to rise by 46% by
2030 (Benjamin et al., 2017). Uncontrolled high-blood pressure (BP), also known as hypertension,
leads to cardiac hypertrophy, systolic and diastolic dysfunction, progressing into heart failure.
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Each increment of 20 mmHg in systolic BP increases the risk of
heart failure by 56% (Haider et al., 2003). The prevalence of heart
failure particularly with preserved ejection fraction (HFPEF) is
projected to rise significantly over the coming decade (Dunlay
et al., 2017). In United States, it is projected that the prevalence
of heart failure will increase by 25% from 2015 to 2030, with a
concomitant 2–3 fold rise in healthcare costs (Heidenreich et al.,
2011). While the role of aging per se as a cause of heart failure is
unclear, the addition of risk factors such as hypertension is well-
known to be involved in the development of the disease (Dunlay
et al., 2017).
Here we used experimental models to better understand
the pathophysiology of the combination of two key clinical
determinants of HFPEF, hypertension, and aging to identify
mechanisms involved. In this context, we hypothesized that
the use of young animals in experimental models might yield
different results when compared to aging animals, which do
not resemble hypertensive heart failure in humans. Therefore,
the aim of the present study was to characterize the cardiac
phenotype and transcriptome of young and aging mice
undergoing hypertension due to a mineralocorticoid-excess, to
determine the molecular mechanisms involved in each age group
and to identify which one is more relevant for translational
studies.
MATERIALS AND METHODS
Animal Model and Treatment
Male C57Bl/6 mice at either 10- (“young”) or 36-weeks
of age (“aging”) underwent a left unilateral uninephrectomy
and were randomly allocated to have a slow-release 21 days
deoxycorticosterone acetate (DOCA; Innovative Research of
America) or a placebo pellet implanted in the right flank while
anesthetized with isoflurane (n = 6–8 per group). After 21 days,
an additional pellet was implanted in the left flank for the
remainder of the experiment for a total of 6 weeks, when mice
were euthanized at 16- or 42-weeks of age. All animals were
provided 1% saline and had access to food and water ad libitum
during the course of the study. Animals were monitored and
weighed regularly over the protocol. All experimental protocols
were approved by the Alfred Medical Research and Education
Precinct Animal Experimentation Ethics Committee under the
guidelines of the National Medical and Health Research Council
of Australia. Echocardiography, cardiac catheter, RNA extraction,
and library preparation and their analyses were performed
blindly. No animals were excluded from the study.
Functional Measurements
The day prior to the completion of the study, mice were
anesthetized using isoflurane and echocardiography was
performed to image the left ventricle using a PHILIPS IE33
ultrasound machine (Royal Philips Electronics, Amsterdam,
Netherlands) with a 15-MHz linear transducer. Images were
analyzed blind. Immediately prior to the completion of the study,
mice were anesthetized with isoflurane and a 1.4F microtipped
transducer catheter (Millar, Houston, TX, United States) was
used to measure arterial BP and determine left ventricular
end-diastolic pressure (LVEDP).
Morphological Analyses
Following cardiac catheter, a blood sample, the heart, kidney,
and lung were rapidly removed. The tissues were weighed, before
being snap frozen in liquid nitrogen and stored at−80◦C or fixed
in 10% formalin.
Histological Analyses
Paraffin sections were cut in 4 µm sections and stained with
Masson’s trichrome in order to analyze the collagen present in
heart samples. Perivascular and interstitial fibrosis levels were
quantified in the heart in 10 random fields of view per section
using an Olympus BH2 microscope (400× magnification) and
ImagePro Plus software (Adept Electronic Solutions, Pty Ltd.,
Moorabbin, VIC, Australia). Collagen levels were expressed as a
percentage of the area of the region of interest.
Statistical Analyses
GraphPad Prism (version 6) package was used for the statistical
analysis and graphing. Normal distribution of data was
verified using Shapiro–Wilk’s normality test. Two-factor analysis
of variance (ANOVA; with Benjamini and Hochberg’s false
discovery rate adjustment for multiple comparisons – not for
repeated measures) was used to compare the data between the
disease models (sham and DOCA) and age (young and aging).
Values are presented as mean± SEM, and those with a P (or q for
multiple comparisons when there were more than two groups)
<0.05 were considered significant.
Cardiac Transcriptome
To understand the molecular mechanisms involved in the
increase in cardiac fibrosis and worsening of the DOCA
phenotype with aging, we examined the cardiac transcriptome
between young and aging sham and DOCA (n = 6 young sham,
others n = 4 per group). Tissue was collected as described
above. RNA was extracted using the RNeasy (Qiagen) kit,
and DNase treated. RNA quality was assessed on MultiNA
bioanalyzer (Shimadzu). A total of 200 ng RNA underwent
ribosomal RNA (rRNA) depletion using the NEBNext R© rRNA
Depletion Kit followed by library construction using NEBNext R©
UltraTM Directional RNA Library Prep Kit for Illumina R© (both
from NEB). Library QC was performed by MultiNA Bioanalyzer
(Shimadzu) and then pooled to equimolar concentration. Pooled
libraries underwent Illumina single read sequencing at the
Australian Genome Research Facility (AGRF, Melbourne, VIC,
Australia) using HiSeq v4 reagents to generate 100 bp reads.
Bioinformatic Analyses
Reads were trimmed for quality using a minimum phred value
of 20 and minimum length of 18 using FastX Toolkit (Cox and
Mann, 2012). Reads were mapped with STAR (Li et al., 2014)
to the mouse genome downloaded from Ensembl (GRCm38).
rRNA carryover was quantified by mapping reads to 5S, 18S, 28S,
and Rs5-8s1 sequenced with BWA aln (Houweling et al., 2005).
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FIGURE 1 | Blood pressure (BP) and left ventricular end-diastolic pressure (LVEDP) of young and aging sham and DOCA mice. (A) Systolic BP and (B) diastolic BP
were higher in young and aging DOCA compared to sham mice. (C) Mean arterial pressure was only significantly higher in young DOCA compared to sham mice.
(D) LVEDP was only significantly higher in aging DOCA compared to sham mice. Values are mean ± SEM. ∗q < 0.05, ∗∗q < 0.01, ∗∗∗q < 0.001 DOCA vs. sham
control. Sample size: aging DOCA n = 8, all other groups n = 6.
FeatureCounts (Zhang and Kass, 2011) was used to count reads
mapped to gene bodies on the correct strand with a minimum
mapping quality of 20 using Ensembl genome annotation (Mus
musculus.GRCm38.85.gtf). Genes with <10 reads per sample
on average were excluded prior to differential analysis with the
EdgeR package (Stec et al., 2000) to determine the contrast
between groups (young sham vs. DOCA and aging sham vs.
DOCA). EdgeR FDR< 0.05 is considered statistically significant.
Mean difference plots were generated in R. Genes were ranked
from most up-regulated to most down-regulated by multiplying
the sign of the log2 fold change by the inverse of the P-value.
This preranked list was used for pathway analysis using gene-
set enrichment analysis (GSEA) (Glasscock et al., 2015). Gene
sets used included REACTOME (Reed et al., 2011), Molecular
Signatures Database (MSigDB) (Koch et al., 2013), and Encode
TFBS we have used previously (Forman et al., 1997). GSEA
FDR < 0.05 is considered statistically significant.
Gene Set Heat Map
Gene-set enrichment analysis is useful to determine whether a
gene set is up- or down-regulated, but it lacks the ability to
visualize intragroup variability. We developed Gsheat, which
scores gene set activation in each sample. Starting from raw
counts, genes are ranked from least expressed (smallest number)
to most expressed (biggest number). Gsheat calculates the sum of
all the ranks for all member genes in each sample for each gene
set. This score is then used to generate a matrix with gene sets
as rows and samples as columns Limma package (Ritchie et al.,
2015) is used to determine whether the gene sets are differentially
expressed between groups. The top gene sets by significance are
extracted and used to generate a heat map, with bright yellow
indicating high expression and dark red low expression. The
results were uploaded into Enrichment Map (Hacker et al., 2006),
a plugin of Cytoscape (v3.4.0) (Yang et al., 2008), to build pathway
networks.
Multi-Contrast Enrichment
It is common to perform pathway analysis with a single
dimension, but we are also interested in gene set regulation in
multidimensional comparisons. In this study, we are looking at
gene sets that are altered in two contrasts: young sham vs. young
DOCA against aging sham vs. aging DOCA. To achieve this, we
first rank genes in each contrast and paste these data side by
side. Next, we calculate enrichment score(s) for each gene set in
two dimensions as described previously (Cox and Mann, 2012).
Gene sets were additionally sourced from the Starbase project
webpage to investigate microRNA (miRNA) targets (Li et al.,
2014).
RESULTS
Hemodynamics
As expected, DOCA administration led to a significant increase
in systolic (Figure 1A) and diastolic BP (Figure 1B) independent
of age. DOCA was the only determinant of the increase in
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TABLE 1 | Serial echocardiographic examination in sham and DOCA mice between young and aging groups.
Young Aging Two-way ANOVA %, P-value
Sham DOCA Sham DOCA Interaction Age Disease
IVSd (mm) 0.69 ± 0.03 1.02 ± 0.05 0.67 ± 0.03 1.01 ± 0.03 0.004%, P = 0.95 0.33%, P = 0.56 80.6%, P < 0.0001
IVSs (mm) 1.14 ± 0.03 1.31 ± 0.04 1.04 ± 0.03 1.37 ± 0.04∗ 12.8%, P = 0.052 3.8%, P = 0.27 26.2%, P = 0.0078
LVIDd (mm) 3.94 ± 0.07 3.72 ± 0.16 3.85 ± 0.05 3.66 ± 0.13 0.04%, P = 0.93 1.7%, P = 0.53 12.3%, P = 0.10
LVIDs (mm) 2.55 ± 0.07 2.48 ± 0.16 2.68 ± 0.04 2.41 ± 0.17 2.5%, P = 0.46 0.3%, P = 0.81 7.5%, P = 0.21
LVPWd (mm) 0.72 ± 0.03 0.85 ± 0.04∗ 0.73 ± 0.02 0.88 ± 0.01∗∗ 1.7%, P = 0.40 2.6%, P = 0.31 46%, P < 0.0001
LVPWs (mm) 1.12 ± 0.04 1.13 ± 0.03 0.96 ± 0.04 1.21 ± 0.05∗∗ 19.4%, P = 0.017 2.0%, P = 0.41 24.1%, P = 0.0086
Fractional shortening (%) 35% ± 2 34% ± 3 30% ± 2 35% ± 3 5.5%, P = 0.28 3.0%, P = 0.42 1.6%, P = 0.56
All results are shown as mean ± SEM. Sample size: n = 6 per group for all groups besides aging DOCA (n = 7). Sham vs. DOCA. ∗q < 0.05, ∗∗q < 0.01. LVIDs,
left ventricular internal dimension systolic; LVIDd, left ventricular internal dimension diastolic; FS, fractional shortening; LVPWd, left ventricular posterior wall dimension at
diastole; LVPWs, left ventricular posterior wall dimension at systole; IVSd, interventricular septal dimension at diastole; IVSs, interventricular septal dimension at systole.
FIGURE 2 | Cardiac fibrosis of young and aging sham and DOCA mice. (A) Young and aging DOCA mice had higher perivascular and (B) interstitial fibrosis than
sham mice. However, aging mice had more perivascular fibrosis than young mice. Values are mean ± SEM. ∗q < 0.05, ∗∗q < 0.01, ∗∗∗q < 0.001 DOCA vs. sham
control. ###P < 0.001 young vs. aging DOCA. Scale bar: 50 µm. Sample size: aging DOCA n = 8, all other groups n = 6.
BP, accounting for 78% of high-systolic BP and 54% of high-
diastolic BP. Mean arterial pressure (MAP) was significantly
higher in young and aged DOCA mice compared to age-matched
sham mice (Figure 1C). Administration of DOCA only led
to a significant increase in LVEDP in aging mice (q = 0.02,
Figure 1D), but there was no difference between young and aging
DOCA mice (q= 0.57).
Cardiac Remodeling
Young DOCA-treated mice had increased heart:body weight
ratio compared to age-matched sham mice (mean ± SEM: sham
5.1 ± 0.2 mg/g vs. DOCA 6.6 ± 0.2 mg/g, P = 0.005), while
no difference was observed between aging sham vs. DOCA mice
(sham 4.9 ± 0.1 mg/g vs. DOCA 5.4 ± 0.4 mg/g, P = 0.47).
Both young and aging DOCA mice had higher kidney:body
weight ratio compared to age-matched controls (young sham
9.6 ± 0.7 mg/g vs. DOCA 16.6 ± 0.3 mg/g, P < 0.0001; aging
sham 9.13 ± 0.3 mg/g vs. DOCA 12 ± 0.8 mg/g, P = 0.005), but
young DOCA had a significantly higher ratio than aging DOCA
mice (P < 0.0001). There was no difference in lung:body weight
ratio in either age or disease groups (data not shown).
Independent of age, DOCA mice displayed echocardiographic
features of cardiac hypertrophy. This included an increase
in the left ventricular posterior wall dimension at diastole
Frontiers in Physiology | www.frontiersin.org 4 July 2018 | Volume 9 | Article 817
fphys-09-00817 July 5, 2018 Time: 19:56 # 5
Marques et al. Young and Aging Hypertensive Hearts
FIGURE 3 | Cardiac transcriptome in young sham vs. DOCA mice. (A) Principal component analyses shows lack of sample group clustering on the first two
dimensions for young sham vs. DOCA mice. (B) MA plot showing 899 differentially expressed genes (FDR < 0.05; Supplementary Table S3). Mechanisms
differentially regulated between young sham and DOCA mice in the (C) GSEA analysis of Reactome Database and (D) Gsheat analysis of Molecular Signatures
Database (MSigDB) (Supplementary Table S4). Sample size: n = 6 young sham vs. n = 4 young DOCA mice. CPM, counts per million; YD, young DOCA; YS, young
sham.
(LVPWd) compared to age-matched sham mice (Table 1). The
LVPWd was significantly greater in the context of both age and
disease response as indicated by the interaction term (Table 1).
Intraventricular septum in systole (IVSs) was increased in aged
DOCA only (Table 1).
Consistent with prior studies, DOCA treated mice
developed extensive perivascular and interstitial cardiac
fibrosis (Figures 2A,B). The perivascular collagen volume
fraction was 23.6 ± 1.1% (mean ± SEM) in young DOCA, while
this was significantly greater in aging DOCA mice at 36.1± 1.4%
(P < 0.0001). In contrast, the extent of interstitial fibrosis was
7.33 ± 0.37% in young DOCA mice and 7.17 ± 0.37% in aging
DOCA mice and the difference was not significantly difference
(q= 0.818).
Transcriptomic Analyses
The Supplementary Table S1 summarizes the quality metrics
supplied by STAR. On average, the read length was 99 nt.
Uniquely mapped read count was high at >80% for all
samples except one sample (14AH2), which contained
a higher proportion of rRNA reads and belongs to the
young DOCA group. We then assigned the reads to genes
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FIGURE 4 | Cardiac transcriptome in aging sham vs. DOCA mice. (A) Principal component analysis confirmed that aging sham and age-matched DOCA mice
formed two distinctive groups. (B) MA plot showing 37 genes were differentially expressed between the two groups (FDR < 0.05; Supplementary Table S5).
Mechanisms differentially regulated between aging sham and DOCA mice in the (C) GSEA analysis of Reactome Database and (D) Gsheat analysis of Molecular
Signatures Database (MSigDB) (Supplementary Table S6). Sample size: n = 4 per group. CPM, counts per million; OD, aging DOCA; OS, aging sham.
(Supplementary Table S2). Prior to differential expression
analysis, we perform a filtering to remove genes that have fewer
than 10 reads on average. From 48,526 genes we initially began
with, we are left with 14,410 after filtering.
Young Sham vs. DOCA
We next compared the cardiac transcriptome of young sham vs.
DOCA mice. While the principal component analyses (PCA) did
not show a clear cluster on the first two principle components
(Figure 3A), there were 899 differentially expressed genes
(FDR < 0.05), of which 435 were up- and 464 were down-
regulated (Figure 3B and Supplementary Table S3). This included
up-regulation of genes previously associated with heart failure
including genes for the natriuretic peptide A (Nppa) (Houweling
et al., 2005), phosphodiesterase 5A (Pde5a) (Zhang and Kass,
2011), and fibrinogen (Fgb) (Stec et al., 2000). Pathways related
to respiratory electron chain were up-regulated, while those
related to immune system, cytokine and platelet signaling, and
nerve growth factor were down-regulated (Figures 3C,D and
Supplementary Table S4). Moreover, the unsupervised heat map
analysis of the MSigDB supports different clustering between
young sham and DOCA mice (Figure 3D).
Aging Sham vs. DOCA
Principal component analyses confirmed that aging sham
and age-matched DOCA mice formed two distinctive groups
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FIGURE 5 | Venn diagrams showing number of genes differentially expressed between (A) sham vs. DOCA mice according to age group (young vs. aging) and
genes in common between the two groups; and (B) young and aging mice according to cardiovascular health (sham vs. DOCA). All genes in (A) and (B) are
FDR < 0.05. (C) Rank–rank plot of all detected genes between young and aging DOCA mice showing they have similar patterns of gene expression.
FIGURE 6 | Enrichment map highlighting major pathway up- (red) or down-regulated (blue) with aging. Showing reactome pathways (Supplementary Table S8) that
had false discovery rate <0.05 in the gene-set enrichment analysis.
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FIGURE 7 | Two-dimensional pathway analysis showing differences between young and aging DOCA mice. Compared to young mice, aging DOCA mice had higher
(A) collagen formation, (B) extracellular matrix organization, and (C) wound healing. (D) Both young and aging DOCA mice had activation of the respiratory electron
transport chain. (E) Young DOCA mice had activation of oxidation and (F) potassium channels. On the other hand, aging DOCA had higher activation of TGF-beta
(G) receptor and (H) targets, and (I) TNF-alpha genes. Sample size: n = 6 young DOCA vs. n = 4 aging DOCA mice.
(Figure 4A). Thirty seven genes were differentially expressed
between the two groups, 11 genes were down- and 26 were up-
regulated (Figure 4B and Supplementary Table S5). This included
the up-regulation of the gene for collagen VIII (Col8a1), and
the down-regulation of the mineralocorticoid receptor Nr3c2.
Potassium voltage-gate Kcna1 was highly down-regulated and
has been previously associated with atrial fibrillation (Glasscock
et al., 2015). Overall in aging DOCA we observed a significant
increase in pathways for collagen formation and apoptosis, an
enrichment of the innate immune system, inflammasomes, and
platelet activation, signaling and aggregation (Supplementary
Table S6). We also observed a decrease in voltage-gated
potassium channels (Figures 4C,D).
Genes in Common Between Young and
Aging DOCA
When comparing the two age groups, only seven genes were
consistently differentially expressed between sham and DOCA
below the significance threshold (FDR < 0.05): Creb1, Irf2bp2,
Itgb6, Jun, Mt1, St3gal5, and Xdh (Figure 5A). This suggests
that different genes and, potentially, mechanisms are involved
in the development of heart disease with aging in the DOCA
model. Moreover, we found that only 272 genes were in common
between young vs. aging sham (equivalent to only 11% of all
differentially expressed genes) or DOCA (42% of all differentially
expressed genes) (Figure 5B). This also suggests that mechanisms
of aging are different between healthy and diseased hearts.
However, when we performed a rank–rank plot to visualize how
similarly genes behave at the transcriptome-wide level, we found
that the two age contrasts have similar patterns of gene expression
(Figure 5C). This prompted us to explore in detail the pathways
involved in the development of heart failure with aging in the
DOCA model.
Pathways in Opposite Direction Between
Aging Sham and DOCA
In factorial analysis of gene expression, 30 genes were up-
regulated and 32 were down-regulated between young and
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FIGURE 8 | Two-dimensional pathway analysis showing the activation of the immune system and inflammation in DOCA mice. (A) The immune system and
(B) adaptive immune system were up-regulated in both ages. (C) The innate immune system, (D) cytokine, and (E) platelet signaling, among other inflammatory
markers, were specifically up-regulated in aging DOCA mice only. Sample size: n = 6 young DOCA vs. n = 4 aging DOCA mice.
aging DOCA (Supplementary Figure S1 and Supplementary
Table S7). Using the Reactome database for young DOCA,
there was the up-regulation of pathways related to respiratory
electron transport chain and oxidation, nitric oxide signaling,
potassium channels, and cholesterol biosynthesis (Figure 6 and
Supplementary Table S8). Some of these findings, particularly
the increase in oxidative stress and respiratory electron
transport chain, were also apparent in the analysis of an
independent database (MsigDB) (Supplementary Table S9).
In aging DOCA, we observed an increase in cytokine and
platelet signaling, (innate) immune system, inflammasomes,
angiogenesis, response to wound healing, TNF-alpha, and
collagen formation (Supplementary Tables S8, S9). Commonly
up-regulated pathways in both young and aging DOCA related
to cell cycle (e.g., DNA replication) and down-regulation of fatty
acid metabolism and endoplasmic reticulum N-glycan/calnexin
pathways. These findings are summarized in Figure 6, which
shows the contrast between ages and disease state according to
MsigDB pathways, and Supplementary Figures S2, S3 which show
an enrichment map for the pathways dysregulated according to
age and support that age is a stronger phenotype than disease.
We then performed two-dimensional (2D) pathway analysis
to identify patterns of DOCA responsive regulation in young
and aging mice. These analyses are unique as they allow
us to visualize the regulation of genes that are specific to
each age. For example, they show clearly the activation of
pathways that are a hallmark of fibrosis including collagen
formation, extracellular matrix organization, and wound healing
in aging DOCA only (Figures 7A–C). These are most likely
independent of activation of pathways associated with the
respiratory electron chain transport, as this was up-regulated
in both ages (Figure 7D), while oxidation was only up-
regulated in young DOCA (Figure 7E) and potassium channels
were down-regulated in aged DOCA as compared to young
DOCA (Figure 7F). On the other hand, aging DOCA had
higher activation of TGF-beta receptor and TNF-alpha genes
(Figures 7G–I). Importantly, while the (adaptive) immune
system in general was up-regulated in both ages, the innate
immune system, cytokine, and platelet signaling, among other
inflammatory markers, were specifically up-regulated in aging
DOCA only (Figure 8).
We also performed a transcription factor target analysis
which showed the common up-regulation of E2f4, Sin3A, and
Foxm1 targets (Figures 9A–C). However, it was apparent that
expression levels of very few target genes were down-regulated
in both ages with the DOCA phenotype. There were several
transcription factor target sets with increased expression in older
hearts and lower expression in younger hearts, including Nfkb,
Fosl2, Zbtb7a, and Stat3 (Figure 9). On the other hand there
were few with increases in young hearts and decreases in older
hearts, the best example being Srebp2 (Figure 9). To address the
observation that expression of only a few transcription factors
targets were elevated in DOCA mice we explored the hypothesis
that this may be due to general transcriptional activation due
to stress and that the down-regulated genes could be the result
of other mechanisms of regulation including small-RNA based
degradation. We ran a 2D pathway analysis using gene sets
previously mined from starBase which contains curated lists
of targets of miRNAs determined empirically. Of interest, the
results were dominated by miRNAs whose targets are repressed
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FIGURE 9 | Two-dimensional pathway analysis of transcription factors, showing up-regulation of (A) Sin3A, (B) FOXM1, and (C) E2F4 targets. However, it caught
our attention that very few were down-regulated in both ages with the DOCA phenotype. There were several transcription factors with increased expression in older
hearts and lower expression in younger hearts, including (D) Nfkb, (E) Fosl2, (F) Zbtb7a, and (G) Stat3. (H) On the other hand there were few with increases in
young hearts and decreases in older hearts, the best example being Srebp2. Sample size: n = 6 young DOCA vs. n = 4 aging DOCA mice.
in both young and older mice, including a list of 267 miRNAs
(Supplementary Table S10 and examples in Figure 10).
DISCUSSION
This study reports, for the first time, a detailed integrative
study of phenotype and cardiac transcriptomics in regard to
the effects of aging in the context of a hypertensive stimulus.
Importantly, although the diseased cardiovascular phenotype
was mostly consistent between different ages, aging mice
had higher markers of cardiac stiffening, such as LVEDP
and perivascular fibrosis, than young mice exposed to the
same phenotype. Combined with the transcriptomic results,
our findings suggest that hypertensive heart failure might
develop through different mechanisms according to age, and
as such these findings are of direct relevance to human
disease. In young mice, hypertension was associated with higher
expression of genes involved in oxidative stress in the heart,
likely due to activation of the respiratory electron transport
chain, while in aging mice collagen formation (measured as
mRNA and protein) was associated with high transcriptomic
activity of the innate immune system and several markers
of inflammation including cytokine and platelet signaling.
Only seven genes, including Creb1, Irf2bp2, Itgb6, Jun, Mt1,
St3gal5, and Xdh were concomitantly dysregulated in both
ages in DOCA mice, but targets for 267 miRNAs were down-
regulated.
Aging models of cardiac dysfunction have been previously
proposed. This includes the spontaneous senescence-prone
(SAMP8) mice (Reed et al., 2011), male FVB/N mice (Koch
et al., 2013), Fischer 344 rats (Forman et al., 1997), and crossed
between Fischer 344 and Brown Norway rats (Hacker et al., 2006).
These models, however, are not specific of HFPEF and present
several other aging phenotypes. SAMP8 mice, for example, did
not develop heart failure despite evidence of diastolic dysfunction
(Reed et al., 2011). In others, the development of heart failure was
sex-specific (Forman et al., 1997; Koch et al., 2013). A common
factor in aging models, however, was increased cardiac fibrosis
with higher inflammatory markers (Hacker et al., 2006; Reed
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FIGURE 10 | Two-dimensional pathway analysis of microRNAs whose targets were down-regulated in both young and aging DOCA mice (full list at Supplementary
Table S10). Showing some examples including (A) let-7B, (B) let-7c, (C) let-7e, and (D) miR-122.
et al., 2011), which is consistent with the present study. While
we observed a clear cluster in the PCA of aged mice (Figure 3A),
this was not detected in young mice (Figure 2A), but the heat
map (Figure 3D) supports different pathways in young sham and
DOCA mice (Figure 2). However, when we compared young vs.
aged DOCA mice (Supplementary Table S9), it is clear that young
DOCA mice are a distinctive group.
Significant age-dependency of cardiovascular responses
following disease insult have previously been reported. We
(X-JD) previously reported that the incidence of cardiac rupture
and remodeling following myocardial infarction was higher in
12-month old compared to 3-month old mice (Yang et al., 2008).
This included higher BP and left ventricle chamber dilation,
but also inflammatory cytokines and collagen levels (Yang et al.,
2008). Along this line, our present study reveals significant
differences in cardiac phenotypes between 42 weeks and younger
(16 weeks) mice. Such age-gap might not appear very large, but
it is sufficient to affect cardiovascular responses to pathological
stress.
Our findings of increased transcription of oxidative stress
genes in young DOCA mice are consistent with previous studies
that used similarly younger mice (Mohammed et al., 2010;
Lovelock et al., 2012). In aging DOCA, we observed higher
levels of collagen protein, collagen formation pathways and
expression of the Col8a1. Col8a1 is a short-chain collagen which
protein is present in the adult and developing heart, smooth,
and skeletal muscle among other tissues (Sage and Iruela-
Arispe, 1990; Uhlen et al., 2015). Lack of Col8a1 reduced cardiac
fibrosis in a transverse aortic constriction (TAC) model, and
decreased myofibroblast differentiation in vitro (Skrbic et al.,
2015). Human macrophages were shown to secrete Col8a1
in vitro (Weitkamp et al., 1999). While there appears to be a
link between macrophages, Col8a1 and vascular remodeling in
response to injury (Sibinga et al., 1997; Weitkamp et al., 1999),
a role for macrophages secreting Col8a1 in the hypertensive
heart is still to be determined. Compared to young DOCA
mice, aging DOCA mice also had activation of axon guidance
(Supplementary Table S8), which might be related to the
activation of cardiac sympathetic innervation, known to have a
role in heart failure and the aging human heart (Kaye and Esler,
2005).
The DOCA model was also associated with down-regulation
of targets for 267 miRNAs (Supplementary Table S10). Among
these were targets of miRNAs we previously described to be
released from the failing heart, including let-7b-5p, let-7c-5p, let-
7e-5p, and miR-122-5p (Figure 8; Marques et al., 2016). Levels
of miR-30c, miR-146a, and miR-221 were lower in both types of
heart failure (Watson et al., 2015), while miR-190 and miR-545-
5p were specific to HFPEF patients relative to control subjects
(Wong et al., 2015). The miR-29 family was recently shown to
regulate the Wtn signaling, resulting in cardiac hypertrophy and
fibrosis (Sassi et al., 2017). This is consistent with our findings
that support that hundreds of targets of miR-29a, miR-29b,
and miR-29c were down-regulated in young and aging DOCA
(Supplementary Table S10).
To further understand the molecular mechanisms behind
heart failure in the aging hypertensive heart, future studies should
take advantage of new single-cell RNA-sequencing techniques, or
isolation of specific cell lines as recently done by us (MZ, AK,
and AE-O) (Quaife-Ryan et al. (2017). Specifically, in the current
study we demonstrated evidence of accentuated perivascular
fibrosis in aging mice. The origin of the perivascular fibrosis was
not determined in our study. Previously, we showed that only
a modest proportion of the cardiac fibroblasts in the fibrotic
myocardium are derived from bone marrow (Chu et al., 2010)
suggesting that the majority of fibrosis arises from resident
cardiac fibroblasts. As such, in the context of perivascular fibrosis,
it is possible that proliferation of pericytes play an important role
(Travers et al., 2016). Future studies should also explore aging in
other models of cardiovascular disease, such as the angiotensin
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II and TAC models. Our findings also need to be replicated in
female mice, as half of heart failure patients are women (Dunlay
et al., 2017). Finally, we did not validate the pathways identified
due to lack of tissue. Although our data was supported by findings
in previous studies, including in human heart failure, further
studies will have to establish the reasons behind the preferred
transcriptome regulation by miRNAs instead of transcription
factors.
Rodent models are particularly useful to study human disease
due to their small size, lower cost, and shorter lifespan compared
to large animal models. Although animal models are invaluable to
advance medical research, few pre-clinical models indeed fulfill
the clinical features of HFPEF (Conceicao et al., 2016). The
current crisis in lack of reproducibility of findings from pre-
clinical to clinical studies and, thus, low translation of findings
to the clinic, has unleashed a call for improved methodological
rigor (Ramirez et al., 2017). Rodent models of HFPEF have been
reviewed somewhere else (Conceicao et al., 2016). Particularly
interesting was the combination of DOCA with TAC models as a
model of HFPEF (Mohammed et al., 2010). We propose, however,
that using models that resemble more closely heart failure such as
combining hypertension and aging might improve translation, as
the molecular mechanisms behind the phenotype would be more
relevant.
CONCLUSION
Our cardiac transcriptomic findings support that the molecular
mechanisms behind the development of hypertension change in
the context of aging. With aging, there was the up-regulation
the (innate) immune system, together with activation of platelet
and cytokine signaling, supporting higher levels of inflammation
that may lead to the higher collagen formation observed (both
in phenotype and molecular level). These data provide new
insights into potential therapeutic targets for hypertensive heart
failure and also highlight the importance of using aging mice in
experimental studies.
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